Physician profile
Ryan M Proctor
NPI 1972861326
$2,377.58
in general payments reported to CMS, 2019-2025
17 companies · $951 in 2025
The $951 reported for 2025 was more than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $301 · 2021: $133 · 2022: $238 · 2023: $293 · 2024: $200 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,345 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.69 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $795.25 | 2019-2025 | |
| Galderma Laboratories, L.P. | $492.31 | 2025 | Nemluvio |
| Amgen INC. | $225.33 | 2019-2022 | |
| Janssen Biotech, INC. | $126.58 | 2020-2025 | Tremfya |
| Organogenesis INC. | $120.96 | 2020-2024 | Puraply Franchise, Puraply |
| Pfizer INC. | $114.90 | 2022-2023 | |
| Leo Pharma INC. | $88.36 | 2023-2025 | Anzupgo, Adbry |
| Regeneron Healthcare Solutions, INC. | $76.05 | 2025 | Dupixent |
| Genzyme Corporation | $66.49 | 2025 | |
| Mimedx Group, INC. | $65.78 | 2025 | |
| Biofrontera INC. | $54.21 | 2021-2024 | Rhodoled Xl, Ameluz, Xepi |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $42.12 | 2023 | Targretin |
| Allergan, INC. | $36.64 | 2019-2020 | |
| Celgene Corporation | $23.12 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.86 | 2023 | Spevigo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $15.63 | 2023 | Vtama |
| Lilly USA, LLC | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Proctor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.